Facebook
Twitter
LinkedIn
ForwardOptimizing Heart Failure & Diabetes Care: Finding Synergy with SGLT-2 Inhibitors
WEBINAR TITLE: Optimizing Heart Failure & Diabetes Care: Finding Synergy with SGLT-2 Inhibitors
LENGTH: 60 minutes
Overall description/goals of webinar: This webinar aims to review the cardiovascular outcomes trials of diabetes agents with a focus on heart failure risk reduction with sodium-glucose cotransporter-2 (SGLT-2) inhibitors. Presenters will offer a practical approach to optimizing pharmacotherapy using patient cases with diabetes and heart failure. In addition, presenters will offer strategies for overcoming barriers encountered with formulary decisions and patient care when considering SGLT-2 inhibitors.
INTRO/CME ANNOUNCEMENT: 5 minutes
PRESENTATION #1: _25__ minutes
LEARNING OBJECTIVES:
Review evidence evaluating cardiovascular outcomes with SGLT-2 inhibitors.
Identify patients with heart failure for whom SGLT-2 inhibitor therapy should be considered.
Given a patient with heart failure and comorbid diabetes, develop a practical approach for optimizing heart failure pharmacotherapy using SGLT-2 inhibitors.
PRESENTATION #2: _25__ minutes
LEARNING OBJECTIVES:
Describe common barriers to prescribing SGLT-2 inhibitors in patients with heart failure and diabetes, including inpatient formulary considerations, shared responsibility of prescribing and monitoring, and patient access.
Given a patient with diabetes and comorbid heart failure, develop a practical approach for optimizing diabetes pharmacotherapy using SGLT-2 inhibitors.
Target Audience
Pharmacist
Learning Objectives
1. Review evidence evaluating cardiovascular outcomes with SGLT-2 inhibitors.
2. Identify patients with heart failure for whom SGLT-2 inhibitor therapy should be considered.
3. Given a patient with heart failure and comorbid diabetes, develop a practical approach for optimizing heart failure pharmacotherapy using SGLT-2 inhibitors.
4. Describe common barriers to prescribing SGLT-2 inhibitors in patients with heart failure and diabetes, including inpatient formulary considerations, shared responsibility of prescribing and monitoring, and patient access.
5. Given a patient with diabetes and comorbid heart failure, develop a practical approach for optimizing diabetes pharmacotherapy using SGLT-2 inhibitors.
WEBINAR TITLE: Optimizing Heart Failure & Diabetes Care: Finding Synergy with SGLT-2 Inhibitors
LENGTH: 60 minutes
Overall description/goals of webinar: This webinar aims to review the cardiovascular outcomes trials of diabetes agents with a focus on heart failure risk reduction with sodium-glucose cotransporter-2 (SGLT-2) inhibitors. Presenters will offer a practical approach to optimizing pharmacotherapy using patient cases with diabetes and heart failure. In addition, presenters will offer strategies for overcoming barriers encountered with formulary decisions and patient care when considering SGLT-2 inhibitors.
INTRO/CME ANNOUNCEMENT: 5 minutes
PRESENTATION #1: _25__ minutes
LEARNING OBJECTIVES:
Review evidence evaluating cardiovascular outcomes with SGLT-2 inhibitors.
Identify patients with heart failure for whom SGLT-2 inhibitor therapy should be considered.
Given a patient with heart failure and comorbid diabetes, develop a practical approach for optimizing heart failure pharmacotherapy using SGLT-2 inhibitors.
PRESENTATION #2: _25__ minutes
LEARNING OBJECTIVES:
Describe common barriers to prescribing SGLT-2 inhibitors in patients with heart failure and diabetes, including inpatient formulary considerations, shared responsibility of prescribing and monitoring, and patient access.
Given a patient with diabetes and comorbid heart failure, develop a practical approach for optimizing diabetes pharmacotherapy using SGLT-2 inhibitors.
Ted Berei, Pharm.D., MBA, BCPS, BCCP
University of Wisconsin Hospitals and Clinics
600 Highland Avenue | Madison, WI 53705 | F6/133-1530
Cell: 815-979-2260
Twitter: @TedBerei
Heather P. Whitley, PharmD, BCPS, CDCES
Mahlon Turner Fellow in Outreach
Associate Clinical Professor
Department of Pharmacy Practice
Auburn University Harrison School of Pharmacy
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 1.00 Attendance